These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Barnhill RL; Argenyi Z; Berwick M; Duray PH; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Paine S; Piepkorn MW; Prieto V; Rabkin MS; Schmidt B; Selim A; Shea CR; Trotter MJ Am J Surg Pathol; 2008 Jan; 32(1):36-44. PubMed ID: 18162768 [TBL] [Abstract][Full Text] [Related]
25. Characteristics and diagnostic performance of pathologists who enjoy interpreting melanocytic lesions. Radick AC; Phipps AI; Piepkorn MW; Nelson HD; Barnhill RL; Elder DE; Reisch LM; Frederick PD; Elmore JG Dermatol Online J; 2018 Jun; 24(6):. PubMed ID: 30142708 [TBL] [Abstract][Full Text] [Related]
26. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions. Serban ED; Farnetani F; Pellacani G; Constantin MM Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304 [TBL] [Abstract][Full Text] [Related]
27. The influence of tumor regression, solar elastosis, and patient age on pathologists' interpretation of melanocytic skin lesions. Titus L; Barnhill RL; Lott JP; Piepkorn MW; Elder DE; Frederick PD; Nelson HD; Carney PA; Knezevich SR; Weinstock MA; Elmore JG Lab Invest; 2017 Feb; 97(2):187-193. PubMed ID: 27892931 [TBL] [Abstract][Full Text] [Related]
28. Digitized whole slides for breast pathology interpretation: current practices and perceptions. Onega T; Weaver D; Geller B; Oster N; Tosteson AN; Carney PA; Nelson H; Allison KH; O'Malley FP; Schnitt SJ; Elmore JG J Digit Imaging; 2014 Oct; 27(5):642-8. PubMed ID: 24682769 [TBL] [Abstract][Full Text] [Related]
29. Terminology for melanocytic skin lesions and the MPATH-Dx classification schema: A survey of dermatopathologists. Radick AC; Reisch LM; Shucard HL; Piepkorn MW; Kerr KF; Elder DE; Barnhill RL; Knezevich SR; Oster N; Elmore JG J Cutan Pathol; 2021 Jun; 48(6):733-738. PubMed ID: 32935869 [TBL] [Abstract][Full Text] [Related]
30. Use of Digital Whole Slide Imaging in Dermatopathology. Onega T; Reisch LM; Frederick PD; Geller BM; Nelson HD; Lott JP; Radick AC; Elder DE; Barnhill RL; Piepkorn MW; Elmore JG J Digit Imaging; 2016 Apr; 29(2):243-53. PubMed ID: 26546178 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL; J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823 [TBL] [Abstract][Full Text] [Related]
32. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium. Sedghizadeh PP; Williams JD; Allen CM; Prasad ML Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678 [TBL] [Abstract][Full Text] [Related]
33. Quality assessment by expert opinion in melanoma pathology: experience of the pathology panel of the Dutch Melanoma Working Party. Veenhuizen KC; De Wit PE; Mooi WJ; Scheffer E; Verbeek AL; Ruiter DJ J Pathol; 1997 Jul; 182(3):266-72. PubMed ID: 9349228 [TBL] [Abstract][Full Text] [Related]
34. The self-reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected states. Zhao G; Lee KC; Kwon G; Frederick PD; Onega TL; Piepkorn MW; Knezevich S; Barnhill RL; Elder DE; Elmore JG J Cutan Pathol; 2016 Jun; 43(6):492-7. PubMed ID: 26968847 [TBL] [Abstract][Full Text] [Related]
35. Assessing comfort level with pediatric skin specimens among dermatopathologists and pediatric pathologists: A national cross-sectional survey. Enos T; Hughes C; Kelley S; Mir A; Rakheja D; Vandergriff T J Cutan Pathol; 2021 Sep; 48(9):1109-1114. PubMed ID: 33635594 [TBL] [Abstract][Full Text] [Related]
36. Clinical Features, Dermoscopic Patterns, and Histological Diagnostic Model for Melanocytic Tumors of Uncertain Malignant Potential (MELTUMP). Pusiol T; Piscioli F; Speziali L; Zorzi MG; Morichetti D; Roncati L Acta Dermatovenerol Croat; 2015; 23(3):185-94. PubMed ID: 26476902 [TBL] [Abstract][Full Text] [Related]
37. Atypical Melanocytic Proliferations: A Review of the Literature. Ensslin CJ; Hibler BP; Lee EH; Nehal KS; Busam KJ; Rossi AM Dermatol Surg; 2018 Feb; 44(2):159-174. PubMed ID: 29059147 [TBL] [Abstract][Full Text] [Related]
38. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. Zembowicz A; Yang SE; Kafanas A; Lyle SR Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223 [TBL] [Abstract][Full Text] [Related]
39. A Comparative Study of the Perspectives of General and Oral and Maxillofacial Pathologists about the Rate and Value of Second Referral in Assessment of Oral and Maxillofacial Pathologic Lesions. Razavi SM; Liaghatdar A; Kargahi N J Cancer Educ; 2018 Oct; 33(5):991-995. PubMed ID: 28211022 [TBL] [Abstract][Full Text] [Related]